Navigation Links
New light microscope sharpens scientists' focus

off the equipment and set up shop in the living room of Hess's condominium in La Jolla, California.

There, in just two months, they built a prototype of the instrument. They also understood, however, that the biology and sample preparation issues would loom just as large as the instrumentation ones. So they contacted Davidson at FSU and Lippincott-Schwartz and Patterson at NICHD. Soon, all three groups were in close cooperation to bring the concept to reality.

By October 2005, the prototype was ready for testing, thanks in part to equipment resources marshaled by the NICHD. Additional financial resources supplied by HHMI ensured that the work would be well funded in the future since Betzig, at almost the same time, accepted a position as a group leader at Janelia Farm.

Betzig exemplified the type of venturesome, creative scientist sought by Janelia Farm, but since the campus was still under construction, it could not yet provide the lab space and collaborative environment he and Hess needed. They therefore moved their prototype to a small space in Lippincott-Schwartz's lab at the NIH. While the cramped quarters and frequent hotel stays were challenging, Hess and Betzig said that being near their collaborators ?who provided the biological expertise that they lacked ?was invaluable as they developed the microscope.

The basic concepts behind their new technique are simple: The researchers label the molecules they want to study with a photoactivatable probe, and then expose those molecules to a small amount of violet light. The light activates fluorescence in a small percentage of molecules, and the microscope captures an image of those that are turned on until they bleach. The process is repeated approximately 10,000 times, with each repetition capturing the position of a different subset of molecules.

Because the number of molecules captured in each image is small, they are far enough apart to see each molecule indivi
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3 4 5 6

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
3. Bacteria collection sheds light on urinary tract infections
4. Sea skate experiment sheds light on human cell transport
5. X-Ray Beams And Fruit Fly Flight Simulator Aid Scientists View Of Muscle Power
6. McGill researchers shed light on formation of carcinogen in food
7. Scientists discover how plants disarm the toxic effects of excessive sunlight
8. Medical molecules designed to respond to visible light that can penetrate tissue
9. Genetic defects give the immune system the green light to attack the pancreas
10. Researchers find gene that may be at root of potato blight
11. Remote control flies? Fly behavior controlled by laser light

Post Your Comments:
(Date:11/25/2009)... Kent State University assistant professors recent...dation (NSF) to continue research beneficial to un...l $890,000. , Christopher Blackwood, assistant p... was awarded grants to support two separate resear...ling Litter Decomposer Communities and Functions f...
(Date:11/24/2009)...entists have crystallised a protein that may help ...he protein could be used by probiotic producers to...nefit to people. , "Probiotics need to interact w...ct, and if they attach to surfaces in the gut they...ert their activity," says Dr Nathalie Juge from th...
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 26 NTU projects awarded NRF grants 13811 16 NTU projects awarded NRF grants 13811 26 NTU projects awarded NRF grants 13811 36 NTU projects awarded NRF grants 13811 4BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 1BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 2BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 3BPA Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics Free Babies and Toddlers Act 28SB 797 29 56093 4Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 1Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 2
...bite is horrible. The immediate pain of the bite i...n sweating or chills, with numbness, nausea, blurr... over. Such misery is produced by a veritable witc...een thought that the body,s own immune system, rat...rse. But now researchers at the Stanford Universit...
...in can turn on and off a key component of the immu...ic dance, said researchers at the University of So...ecause autoimmune diseases ?such as arthritis, all...he body,s defenses respond at the wrong time or pl...s been the subject of intense study for decades. ...
...sociated with early Alzheimer,s disease (AD) may b...he brain, according to a study in the July issue o...Duke University Medical Center in Durham, N.C., us...netic resonance imaging (fMRI) scanner to study th...itive impairment (MCI), a precursor to AD, and fou...
Other Biology News:Stanford snake venom study shows that certain cells may eliminate poison 2Stanford snake venom study shows that certain cells may eliminate poison 3Stanford snake venom study shows that certain cells may eliminate poison 4Flick of a protein switches immune response 2Memory loss affects more of the brain than previously thought 2
(Date:11/24/2009)... MATEO, Calif., Nov. 24 ...cal company focused on developing and commercializ...ay that Anthony DiTonno, President and Chief Execu...Annual Piper Jaffray Health Care Conference, to be...tel in New York, New York. ,, Mr. DiTonno and ...
(Date:11/24/2009)....24/PRNewswire/--BlueMarbleEnergyCorp.announcedtod...rity(OPDA)wererecentlyawarded$2millionbyWashington...naprivate/publicpartnershiptoconstructthestate,sfi...WA. ,, "Thisinvestmentwillsignificantlyspeedthe...toLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilv...
(Date:11/24/2009)...rimary efficacy endpoint has been met for patients...cancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fi...TSX: AEZ) (the "Company"), a global biopharmaceuti...ogy, today announced positive efficacy data from a... conjugate, AEZS-108 (formerly AN-152), in patient...
(Date:11/24/2009)...BLIN, November 24 Shire ...lty biopharmaceutical company, today,announced tha... Agency for,velaglucerase alfa, the company,s enzy...tment of Type 1 Gaucher disease. This is the third... has been submitted, with previous,submissions in ...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...ealthcare Services,Inc. (NYSE: AHS ), the nation,...d to make a presentation on Tuesday, November 6, 2...arkets 18th Annual Healthcare Conference,taking pl... (Logo: http://www.newscom.com/cgi-bin/prnh/2006... and Chief Executive Officer of AMN,Healthcare, wi...
...Bioscience (OTC,Bulletin Board: PURE), creators of...ive ingredient in a revolutionary new hard surface...her human pathogens,announced that the Company wil...rsday, November 1, 2007 at the San Diego Marriott ...ompany,s patented platform technology,product appl...
...sults support advance to clinical study for third,...he company,s proprietary CombiPl.... 26 Celator Pharmaceuticals today,announced posi...the optimal,ratio of irinotecan and cisplatin to d...r cell lines in vitro. The study further worked to...
Other Biology Technology:AMN Healthcare Services to Present at the CIBC World Markets 18th Annual Healthcare Conference 2PURE Bioscience to Present at Biocom Investors Conference 2PURE Bioscience to Present at Biocom Investors Conference 3PURE Bioscience to Present at Biocom Investors Conference 4Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity 2
Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rhodamine 110 (Fluorescence Reference Standard) from AnaSpec
Mouse Anti-Human PPOX Monoclonal Antibody, Unconjugated, Clone 2F10 from ABR-Affinity BioReagents
Biology Products: